LIFEPOINT HEALTH, INC.·4

Mar 1, 5:55 PM ET

Peters Jennifer C 4

4 · LIFEPOINT HEALTH, INC. · Filed Mar 1, 2018

Insider Transaction Report

Form 4
Period: 2018-02-27
Peters Jennifer C
Gen. Counsel and Corp. Sec.
Transactions
  • Award

    Non-Qualified Stock Options (Right to buy)

    2018-02-27+34,98534,985 total
    Exercise: $44.85Exp: 2028-02-27Common (34,985 underlying)
  • Award

    Restricted Stock Units

    2018-02-27+11,54518,337 total
    Exercise: $0.00Common (11,545 underlying)
Footnotes (2)
  • [F1]The options vest in four equal installments beginning on the first anniversary of the date of grant.
  • [F2]The Performance Period with respect to these restricted stock units ("RSUs") is January 1, 2018 through December 31, 2020. Each RSU represents the right to receive, upon vesting, up to two shares of the Issuer's common stock. Vesting of these performance-based RSUs is contingent upon the achievement of annually established performance targets for diluted earnings per share for each of the three fiscal years of the Performance Period, with the final number of shares of common stock issued under the RSUs subject to modification based on the Issuer's three-year annualized total shareholder return as of December 31, 2020 relative to the S&P GICS Sub-Industry Health Care Facilities with over $500 million in revenues, or its equivalent. Any RSUs earned during the Performance Period will be paid out 75% in 2020 and 25% in 2021, contingent upon continued employment with the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary